• Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Ser206Cys (c.617C>G) (p.Ser219Cys, c.656C>G) (S219C); Zygosity=Heterozygous (PubMed=21179087).
  

PubMed=15122589; DOI=10.1002/ijc.20170
Liggins A.P., Guinn B.A., Hatton C.S., Pulford K., Banham A.H.
Serologic detection of diffuse large B-cell lymphoma-associated antigens.
Int. J. Cancer 110:563-569(2004)

PubMed=18077790; DOI=10.1182/blood-2007-09-115113
Brown P.J., Ashe S.L., Leich E., Burek C., Barrans S., Fenton J.A., Jack A.S., Pulford K., Rosenwald A., Banham A.H.
Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL.
Blood 111:2816-2824(2008)

PubMed=21179087; DOI=10.1038/nature09671; PMCID=PMC5024568
Ngo V.N., Young R.M., Schmitz R., Jhavar S., Xiao W.-M., Lim K.-H., Kohlhammer H., Xu W.-H., Yang Y.-D., Zhao H., Shaffer A.L. 3rd, Romesser P.B., Wright G., Powell J.I., Rosenwald A., Muller-Hermelink H.-K., Ott G., Gascoyne R.D., Connors J.M., Rimsza L.M., Campo E., Jaffe E.S., Delabie J., Smeland E.B., Fisher R.I., Braziel R.M., Tubbs R.R., Cook J.R., Weisenburger D.D., Chan W.-C., Staudt L.M.
Oncogenically active MYD88 mutations in human lymphoma.
Nature 470:115-119(2011)